R. Carmagnani Pestana

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

A. Bardia, G. Curigliano, J. Soria, 2021, CA: a cancer journal for clinicians.

Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients

Jeffrey S. Morris, Manal M. Hassan, S. Dima, 2020, Oncology.

Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials.

K. Hess, V. Subbiah, G. Viola, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Response to Pembrolizumab in Advanced Anal Squamous Cell Carcinoma With High TMB and PD-L1 and PD-L2 Amplification.

R. Carmagnani Pestana, Vanderlei Segatelli, F. Tostes, 2021, Clinical colorectal cancer.

Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma

Manal M. Hassan, A. Rashid, R. Wolff, 2022, Frontiers in Oncology.

Precision Oncology in Sarcomas: Divide and Conquer

Jason Roszik, Vivek Subbiah, Roberto Carmagnani Pestana, 2019, JCO precision oncology.

Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets

J. Roszik, V. Subbiah, V. Ravi, 2019, Cancers.

Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma

L. Mustachio, J. Roszik, V. Subbiah, 2021, Cancers.

Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)

F. Meric-Bernstam, R. Benjamin, A. Naing, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)

F. Meric-Bernstam, A. Lazar, C. Roland, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.